在灾难期间,不要忘记移植患者
Musab S Hommos1, Ashlyn Brown2, Brandon Trollinger3
1Division of Nephrology and Hypertension, Department of Medicine.
Current opinion in nephrology and hypertension
|September 2, 2024
概括
由于依赖医疗保健基础设施,移植接受者在灾难期间面临更大的风险. 应急准备计划对于确保护理的连续性和保护患者健康至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 公共卫生 公共卫生
- 紧急医疗 紧急医疗
背景情况:
- 全球移植接受者的数量增加.
- 自然灾害和人为冲突的频率越来越高.
- 移植患者对医疗保健中断的脆弱性.
研究的目的:
- 解决移植接受者应急准备的关键需求.
- 减轻灾难对这一患者群体的严重影响.
- 在危机期间确保护理的连续性.
主要方法:
- 关于灾难准备和移植的当前文献的综述.
- 在灾难期间,移植接受者面临的风险分析.
- 确定维持护理连续性的策略.
主要成果:
- 接受移植的接受者需要强大的医疗保健基础设施,包括专业人员,诊断和免疫抑制剂.
- 灾害破坏基本服务,增加器官排斥和感染的风险.
- 维持护理连续性的多层次策略是必要的.
结论:
- 有效的灾难准备计划对于接受脏移植的人来说至关重要.
- 关键措施包括药物储备,紧急通讯和患者教育.
- 实施这些计划可以在灾难期间保护移植患者的健康和福祉.
相关概念视频
01:24Tissue Transplantation
346
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
346
01:22Bone Marrow Sampling and Transplants
316
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
316
01:40Cell-mediated Immune Responses
67.9K
Overview
67.9K